Barclays
GOCO

Barclays’s GoHealth GOCO Stock Holding History

Barclays’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Sell
66,170
-2,753
-4% -$2.48K ﹤0.01% 4533
2026
Q1 		$104K Sell
68,923
-12,258
-15% -$23.4K ﹤0.01% 4006
2025
Q4 		$175K Buy
81,181
+7,430
+10% +$25.4K ﹤0.01% 4395
2025
Q3 		$355K Buy
73,751
+61,787
+516% +$337K ﹤0.01% 3995
2025
Q2 		$66.4K Buy
11,964
+3,745
+46% +$29.6K ﹤0.01% 4660
2025
Q1 		$101K Sell
8,219
-2,285
-22% -$34.9K ﹤0.01% 4408
2024
Q4 		$141K Buy
10,504
+924
+10% +$10.5K ﹤0.01% 4480
2024
Q3 		$89.9K Buy
9,580
+4,372
+84% +$44.3K ﹤0.01% 4600
2024
Q2 		$50.6K Sell
5,208
-1,325
-20% -$13.1K ﹤0.01% 4211
2024
Q1 		$68.7K Sell
6,533
-2,801
-30% -$34.6K ﹤0.01% 4544
2023
Q4 		$125K Buy
9,334
+4,978
+114% +$68.1K ﹤0.01% 4582
2023
Q3 		$63.1K Sell
4,356
-70
-2% -$1.21K ﹤0.01% 3766
2023
Q2 		$87.2K Sell
4,426
-4,675
-51% -$73.4K ﹤0.01% 3606
2023
Q1 		$148K Buy
9,101
+5,455
+150% +$84.2K ﹤0.01% 3968
2022
Q4 		$38.1K Sell
3,646
-13
-0.4% -$115 ﹤0.01% 4644
2022
Q3 		$19K Sell
3,659
-1,322
-27% -$9.95K ﹤0.01% 4080
2022
Q2 		$45K Sell
4,981
-949
-16% -$11K ﹤0.01% 4072
2022
Q1 		$104K Buy
+5,930
New +$185K ﹤0.01% 3760

Other funds holding GOCO

EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's GOCO Position: Q2 2026 in Review

Barclays reduced its GoHealth (GOCO) stake by 4% in Q2 2026, selling an estimated $2.48K and leaving 66,170 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4533.

Barclays first reported a position in GOCO in Q1 2022 and has held it in 18 quarters since. The position peaked at $355K in Q3 2025. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Barclays held 66,170 shares of GoHealth worth $25.5K as of Q2 2026.
  • Barclays sold 2,753 GoHealth shares in Q2 2026, an estimated $2.48K.
  • GoHealth made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4533 holding.
  • Barclays first reported a position in GoHealth in Q1 2022 and has held it in 18 quarters since.
  • Barclays's GoHealth position peaked at $355K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.